$SAVA “Treatment also eased depression and dementia-related behaviors in patients, two exploratory trial goals, and simufilam was found to be safe and well tolerated.”

Simufilam reduced dementia-related behavior at 9 months on the Neuropsychiatric Inventory (NPI), a clinical tool widely used to measure changes in dementia-related behavior.

The open label study is a true gift which gives us insight on both health and benefit issues and the med looks great on both counts.

$SAVA September 3rd 2021 Remi Barbier said, "I truly believe Cassava Sciences is one clinical program away from greatness.

$SAVA Per press release dec 6 2022, Remi stated administration of drug for OL study completed and he is "THRILLED" with the clinical development, or what he see to this date.

$SAVA , VERA announced positive phase 2b results meeting primary end point.

My prediction: Phase 2 Unbelievable results FDA fast track Phase 3 - go ahead Patients receive sava Market cap 40 B by 2024 Rising to 200 Billion by 2026 Game changer - the only drug in the world to help patients

At 🌋 phase.

$BBAI They have to factor in the jobs report which was excellent as well, it means that AI isn't going to phase out a key aspect of the economy.

There is minimal "clinical" risk on the BLA; it fulfilled all the endpoints with flying colors and looks safe.

though much more expensive than chemical entities, are generally considered by health care providers and payers to be worth their cost — as long as the appropriate patients receive them and achieve the desired clinical outcomes.

Dilution and CEO July trial is no bueno here 🤗 Puts look wonderful

If you believe in the science and current studies than buying down here is an amazing opportunity that will deliver in time.

Overall well-being health-related quality of life scores for patients treated with omidubicel showed clinical benefit compared to standard of care, the company said.”

but with IBRX current pipeline, peer studies confirming the science, and pending PDUFA for N-803 + BCG I remain bullish.

People who received the trial treatment lived with improved quality and longer.

6) Good possibility of FDA approving our pancreatic cocktail for phase 3 (I think?).

because the trial results show that lives are improved.